Lantern Pharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Lantern Pharma Stock Summary

Lantern Pharma competes with Tff Pharmaceuticals, Generation Bio, Lyra Therapeutics, Immunome, and Cue Biopharma. Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. The company was incorporated in 2013 and is headquartered in Dallas, Texas. Lantern Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

Lantern Pharma Key Financial Ratios

Lantern Pharma Key Balance Sheet Accounts

Lantern Pharma Key Cash Accounts

Lantern Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lantern Pharma's current stock value. Our valuation model uses many indicators to compare Lantern Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lantern Pharma competition to find correlations between indicators driving Lantern Pharma's intrinsic value. More Info.Lantern Pharma is currently regarded as number one stock in return on equity category among its peers. It is rated second overall in return on asset category among its peers . At this time, Lantern Pharma's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lantern Pharma's earnings, one of the primary drivers of an investment's value.

Lantern Pharma Systematic Risk

Today, most investors in Lantern Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Lantern Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Lantern Pharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Lantern Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lantern Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lantern Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Lantern Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lantern Pharma's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.